Bristol-Myers Squibb Co (BMY)
48.78
-0.21
(-0.43%)
USD |
NYSE |
Apr 24, 10:31
Bristol-Myers Squibb Total Liabilities (Quarterly): 65.67B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.67B |
| September 30, 2023 | 62.20B |
| June 30, 2023 | 61.46B |
| March 31, 2023 | 62.40B |
| December 31, 2022 | 65.70B |
| September 30, 2022 | 65.46B |
| June 30, 2022 | 67.70B |
| March 31, 2022 | 71.39B |
| December 31, 2021 | 73.31B |
| September 30, 2021 | 73.61B |
| June 30, 2021 | 73.92B |
| March 31, 2021 | 74.76B |
| December 31, 2020 | 80.60B |
| September 30, 2020 | 75.31B |
| June 30, 2020 | 78.92B |
| March 31, 2020 | 79.31B |
| December 31, 2019 | 78.25B |
| September 30, 2019 | 39.68B |
| June 30, 2019 | 39.01B |
| March 31, 2019 | 19.52B |
| December 31, 2018 | 20.86B |
| September 30, 2018 | 19.98B |
| June 30, 2018 | 20.22B |
| March 31, 2018 | 20.18B |
| December 31, 2017 | 21.70B |
| Date | Value |
|---|---|
| September 30, 2017 | 19.06B |
| June 30, 2017 | 18.59B |
| March 31, 2017 | 18.40B |
| December 31, 2016 | 17.36B |
| September 30, 2016 | 17.95B |
| June 30, 2016 | 17.75B |
| March 31, 2016 | 17.34B |
| December 31, 2015 | 17.32B |
| September 30, 2015 | 16.51B |
| June 30, 2015 | 16.66B |
| March 31, 2015 | 17.89B |
| December 31, 2014 | 18.77B |
| September 30, 2014 | 18.25B |
| June 30, 2014 | 18.12B |
| March 31, 2014 | 17.89B |
| December 31, 2013 | 23.36B |
| September 30, 2013 | 22.09B |
| June 30, 2013 | 21.88B |
| March 31, 2013 | 22.26B |
| December 31, 2012 | 22.26B |
| September 30, 2012 | 22.14B |
| June 30, 2012 | 15.86B |
| March 31, 2012 | 16.16B |
| December 31, 2011 | 17.10B |
| September 30, 2011 | 15.58B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
39.01B
Minimum
Jun 2019
80.60B
Maximum
Dec 2020
67.82B
Average
71.39B
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Amgen Inc | 90.92B |
| Gilead Sciences Inc | 39.38B |
| Johnson & Johnson | 98.78B |
| Karuna Therapeutics Inc (DELISTED) | 81.97M |
| 2seventy bio Inc | 310.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 95.16B |
| Shareholders Equity (Quarterly) | 29.43B |
| Debt to Equity Ratio | 1.351 |
| Current Ratio | 1.427 |
| Net Debt Paydown Yield | -0.13% |